We are live on ! Find out more
AF

Amalgamated Financial Portfolio holdings

AUM $12.6B
This Fund
S&P 500
This Quarter Est. Return
-2.93%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$12.6B
AUM Growth
Cap. Flow
+$12.4B
Cap. Flow %
98.67%
Top 10 Hldgs %
24.33%
Holding
3,002
New
2,999
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$709M
2
MSFT icon
Microsoft
MSFT
+$617M
3
AMZN icon
Amazon
AMZN
+$371M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$223M
5
TSLA icon
Tesla
TSLA
+$208M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 24.52%
2 Financials 13.15%
3 Healthcare 13.05%
4 Consumer Discretionary 12.17%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TX icon
2901
Ternium
TX
$9.67B
$10K ﹤0.01%
+229
New +$9.75K
VALU icon
2902
Value Line
VALU
$321M
$10K ﹤0.01%
+156
New +$9.17K
SYRS
2903
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$10K ﹤0.01%
+811
New +$14.5K
BCEL
2904
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$10K ﹤0.01%
+3,241
New +$7.86K
TCRR
2905
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$10K ﹤0.01%
+3,672
New +$11.6K
TIG
2906
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$10K ﹤0.01%
+2,124
New +$14.3K
STON
2907
DELISTED
StoneMor Inc.
STON
$10K ﹤0.01%
+3,874
New +$9.98K
AC
2908
DELISTED
Associated Capital Group
AC
$9K ﹤0.01%
+203
New +$8.42K
DRIO icon
2909
DarioHealth
DRIO
$70.9M
$9K ﹤0.01%
+81
New +$13.4K
GTBP icon
2910
GT Biopharma
GTBP
$10.6M
$9K ﹤0.01%
+99
New +$8.73K
MBIO icon
2911
Mustang Bio
MBIO
$4.32M
$9K ﹤0.01%
+12
New +$9.86K
NGNE icon
2912
Neurogene
NGNE
$656M
$9K ﹤0.01%
+231
New +$13.5K
NPCE icon
2913
Neuropace
NPCE
$439M
$9K ﹤0.01%
+1,156
New +$9.97K
SLDB icon
2914
Solid Biosciences
SLDB
$794M
$9K ﹤0.01%
+479
New +$8.45K
SPRY icon
2915
ARS Pharmaceuticals
SPRY
$509M
$9K ﹤0.01%
+2,469
New +$10.7K
CLYM
2916
Climb Bio
CLYM
$681M
$9K ﹤0.01%
+1,039
New +$9.69K
TAST
2917
DELISTED
Carrols Restaurant Group, Inc.
TAST
$9K ﹤0.01%
+4,025
New +$10.4K
SRT
2918
DELISTED
Startek Inc.
SRT
$9K ﹤0.01%
+2,027
New +$9.57K
HMTV
2919
DELISTED
Hemisphere Media Group, Inc.
HMTV
$9K ﹤0.01%
+1,949
New +$11.7K
ACIC icon
2920
American Coastal Insurance
ACIC
$515M
$8K ﹤0.01%
+2,448
New +$9.26K
AXDX
2921
DELISTED
Accelerate Diagnostics
AXDX
$8K ﹤0.01%
+537
New +$15.3K
BDTX icon
2922
Black Diamond Therapeutics
BDTX
$96.8M
$8K ﹤0.01%
+2,742
New +$10K
BOLT icon
2923
Bolt Biotherapeutics
BOLT
$7.67M
$8K ﹤0.01%
+138
New +$9.29K
BYSI icon
2924
BeyondSpring
BYSI
$47.3M
$8K ﹤0.01%
+3,647
New +$10.6K
CVRX icon
2925
CVRx
CVRX
$137M
$8K ﹤0.01%
+1,259
New +$10.2K

Similar funds

Amalgamated Financial's Q1 2022 Portfolio in Review

Q1 2022 is the first quarter with a 13F filing on record for Amalgamated Financial, which disclosed 3,002 positions worth $12.6B. Its ten largest holdings account for 24% of the portfolio.

Its largest position is Apple: 4,217,665 shares worth $736M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, followed by Financials and Healthcare.

  • Amalgamated Financial's largest Q1 2022 buy was Apple: 4,217,665 shares worth $736M.
  • Amalgamated Financial's ten largest holdings make up 24% of its $12.6B portfolio in Q1 2022.
  • Amalgamated Financial disclosed 3,002 positions in Q1 2022, its first 13F filing on record.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.